A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40 Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Panorama
Status: Recruiting
Location: See all (25) locations...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 74
Healthy Volunteers: f
View:
• Diagnosis of GAD per DSM-5
• Male or female aged 18 to 74
• HAM-A Total Score ≥20
Locations
United States
Arkansas
Preferred Research Partners, Inc.
RECRUITING
Little Rock
California
Psychedelic Science Institute
RECRUITING
Los Angeles
West Los Angeles VA Medical Center
NOT_YET_RECRUITING
Los Angeles
Cenexel-CNS
ACTIVE_NOT_RECRUITING
Torrance
Florida
Bradenton Research Center, Inc.
RECRUITING
Bradenton
Clinical Neuroscience Solutions, Inc
RECRUITING
Orlando
Georgia
Atlanta Center for Medical Research
ACTIVE_NOT_RECRUITING
Atlanta
Massachusetts
Adams Clinical Boston
ACTIVE_NOT_RECRUITING
Boston
Maryland
Sheppard Pratt Health System
RECRUITING
Towson
New Jersey
Princeton Medical Institute
RECRUITING
Princeton
Ohio
University of Cincinnati Psychiatry- Anxiety Disorders Research Program
RECRUITING
Cincinnati
Neuro-Behavioral Clinical Research, Inc.
RECRUITING
North Canton
Texas
Austin Clinical Trial Partners
RECRUITING
Austin
Utah
Cedar Clinical Research
RECRUITING
Murray
Washington
Core Clinical Research
RECRUITING
Everett
Other Locations
France
CMME
RECRUITING
Paris
GHU Paris Psychiatrie et Neurosciences
RECRUITING
Paris
Germany
Department of Psychiatry and Psychotherapy Campus Charité Mitte Charité Universitätsmedizin Berlin
RECRUITING
Berlin
OVID Clinic Berlin
RECRUITING
Berlin
Central Institute of Mental Health
RECRUITING
Mannheim
Klinik für Psychiatrie und Psychotherapie, Abt: Allgemeine Psychiatrie und Psychotherapie
RECRUITING
Tübingen
Poland
Centrum Badan Klinicznych PI-House sp. z o.o.
RECRUITING
Gdansk
United Kingdom
Clerkenwell Health
RECRUITING
London
Clerkenwell Health - Baker Street
RECRUITING
London
South London and Maudsley NHS Foundation Trust of The Maudsley Hospital
RECRUITING
London
Contact Information
Primary
Mind Medicine, Inc. Clinical Trials Info Requests
ClinicalTrials@Mindmed.co
1-332-282-0479
Time Frame
Start Date: 2025-01-29
Estimated Completion Date: 2027-05
Participants
Target number of participants: 250
Treatments
Placebo_comparator: Arm 1 - Placebo
A substance that is designed to have no therapeutic value
Sham_comparator: Arm 2 - 50µg MM120 (LSD D-Tartrate)
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
Experimental: Arm 3 - 100µg MM120 (LSD D-Tartrate)
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
Related Therapeutic Areas
Sponsors
Leads: Mind Medicine, Inc.